1. Home
  2. KNSA vs KTB Comparison

KNSA vs KTB Comparison

Compare KNSA & KTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

N/A

Current Price

$78.17

Market Cap

4.9B

Sector

Health Care

ML Signal

N/A

Logo Kontoor Brands Inc.

KTB

Kontoor Brands Inc.

N/A

Current Price

$78.26

Market Cap

4.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
KNSA
KTB
Founded
2015
2018
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.3B
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
KNSA
KTB
Price
$78.17
$78.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
9
Target Price
$60.86
$99.67
AVG Volume (30 Days)
667.7K
691.1K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
2.94%
EPS Growth
225.00
N/A
EPS
0.27
2.82
Revenue
$677,564,000.00
$2,097,839,000.00
Revenue This Year
$37.48
$10.39
Revenue Next Year
$17.87
$3.91
P/E Ratio
$299.51
$29.14
Revenue Growth
60.09
N/A
52 Week Low
$32.89
$56.19
52 Week High
$82.94
$88.96

Technical Indicators

Market Signals
Indicator
KNSA
KTB
Relative Strength Index (RSI) 60.67 42.96
Support Level $40.06 $74.38
Resistance Level $82.94 $80.20
Average True Range (ATR) 2.63 3.10
MACD -0.28 -0.24
Stochastic Oscillator 66.49 27.36

Price Performance

Historical Comparison
KNSA
KTB

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

About KTB Kontoor Brands Inc.

Kontoor Brands Inc is a lifestyle apparel company. It designs, manufactures, procures, sells, and licenses apparel, footwear, and accessories, mainly under the brand names Wrangler, Lee, Helly Hansen, and a few other brands. The company also licenses the use of its brands in certain regions. Its products are sold through wholesale and direct-to-consumer channels in the United States (its key revenue-generating market) and internationally, mainly in Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Non-U.S. Americas regions. The company's three reportable segments are Wrangler, Lee, and Helly Hansen. The majority of its revenue is generated from the Wrangler segment, which offers denim, apparel, footwear, and accessories through Wrangler and various sub-brands.

Share on Social Networks: